The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice

Experimental Lung Research

Volumn 40, Issue 3, 2014, Pages 117-125

  Lee, Sang Hoon ^a   Lee, Eun Joo ^a   Lee, Sang Yeub ^a   Kim, Je Hyeong ^a   Shim, Jae Jeong ^a   Shin, Chol ^a   In, Kwang Ho ^a   Kang, Kyung Ho ^a   Uhm, Chang Sub ^a   Kim, Han Kyeom ^a   Yang, Kyung Sook ^a   Park, Sanghoon ^b   Kim, Hyun Soo ^c   Kim, Yong Man ^c   Yoo, Tai June ^d  

^a Korea University College of Medicine   (South Korea)

^b Korea Electric Power Research Institute (KEPRI)   (South Korea)

^c Pharmicell Co Ltd   (South Korea)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adipose stem cell; Bleomycin; Cell therapy; Mouse; Pulmonary fibrosis

Indexed keywords

COLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELL COUNTING; CLARA CELL; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADIPOSE TISSUE; ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; HYDROXYPROLINE; IN SITU NICK-END LABELING; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84896122733     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2014.881930     Document Type: Article

References (29)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Jr., Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
2. Willis BC, duBois RM, Borok Z: Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc. 2006;3(4):377-382. (Pubitemid 43845416)
3. Costabel U, Albera C, Behr J, Cottin V, Guenther A, Richeldi L: Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics. Respir Res. 2013;14(Suppl 1):S1.
4. Mouratis MA, Aidinis V: Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med. 2011;17(5):355-361.
5. Moore BB, Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008; 294(2):L152-160. (Pubitemid 351253350)
6. Degryse AL, Lawson WE: Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci. 2011;341(6):444-449.
7. Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE: Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010; 299(4):L442-452.
8. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, Reynolds S, Rojas M, Stripp B, Warburton D, Prockop DJ: Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc. 2011;8(3):223-272.
9. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO, Feng D, Adamowicz JJ, Van Demark M, Fisher AJ, Kamocki K, Brown MB, Presson RG, Jr., Broxmeyer HE, March KL, Petrache I: Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 2011; 183(2):215-225.
10. Tzouvelekis A, Ntolios P, Bouros D: Stem cell treatment for chronic lung diseases. Respiration. 2013;85(3):179-192.
11. Tzouvelekis A, Antoniadis A, Bouros D: Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med. 2011;17(5): 368-373.
12. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003;100(14):8407-8411. (Pubitemid 36842558)
13. Inamdar AC, Inamdar AA: Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell. Exp Lung Res. 2013;39(8):315-327.
14. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005;33(2):145-152. (Pubitemid 41473051)
15. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004;113(2):243-252. (Pubitemid 38544209)
16. Zhou Y, Yuan J, Zhou B, Lee AJ, Ghawji M, Jr., Yoo TJ: The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology. 2011;133(1):133-140.
17. Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, Freitag-Wolf S, Bewig B: Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507-511, 514-507.
18. Zuk PA, ZhuM,Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228. (Pubitemid 32295155)
19. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T: IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells. 2008;26(10):2705-2712.
20. Mirsaidi A, Kleinhans KN, Rimann M, Tiaden AN, StauberM, Rudolph KL, Richards PJ: Telomere length, telomerase activity and osteogenic differentiation aremaintained in adipose-derived stromal cells from senile osteoporotic SAMP6 mice. J Tissue Eng Regen Med. 2012;6(5):378-390.
21. Chen HT, Lee MJ, Chen CH, Chuang SC, Chang LF, Ho ML, Hung SH, Fu YC, Wang YH, Wang HI, Wang GJ, Kang L, Chang JK: Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med. 2012;16(3):582-593.
22. Mendes SC, Tibbe JM, Veenhof M, Bakker K, Both S, Platenburg PP, Oner FC, de Bruijn JD, van Blitterswijk CA: Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng. 2002;8(6):911-920. (Pubitemid 35397237)
23. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD: Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One. 2008;3(5):e2213.
24. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A, Ray P: Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol. 2009;40(6):643-653.
25. Uji M, Nakada A, Nakamura T: Intravenous administration of adipose-derived stromal cells does not ameliorate bleomycininduced lung injury in rats. Open J Regen Med. 2013; 2(2): 39-45.
26. Kang SK, Shin IS, Ko MS, Jo JY, Ra JC: Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012;2012: 342968.
27. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y, Shi Y: Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med. 2012;1(1): 51-58.
28. Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR: Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med. 2011;37(9):1421-1431.
29. Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N, Dardzinski B, Gritzalis D, Antoniadis A, FroudarakisM, Kolios G, Bouros D: A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013;11:171.